Remove Analysis Remove BioTech Remove Health Policy Remove Life Science
article thumbnail

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies? Translation: watch out for winter and flu season, especially if people don’t re-mask and take care to protect themselves and others — particularly important in geographies where more folks have opted out of getting vaccinated.

BioTech 270
article thumbnail

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Health Populi

In this Vantage analysis , Jonathan Gardner observed that Lilly’s action on generic insulin “took a leaf out of Mylan’s book” in their response to public outcry on EpiPen pricing. . “Humalog isn’t thirteen times as effective as it used to be.